Human umbilical cord mesenchymal stem cells(Qilu Cell Therapy)

人脐带间充质干细胞（齐鲁细胞)

Report date: 2025/04/02 13:36:24

Base Information

Drug NameHuman umbilical cord mesenchymal stem cells(Qilu Cell Therapy)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsDecompensated Liver CirrhosisImmune Reconstitution Inflammatory SyndromeDiabetes Mellitus +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShandong Qilu Cell Treapy Engineering&Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Qilu Cell Treapy Engineering&Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsDecompensated Liver CirrhosisImmune Reconstitution Inflammatory SyndromeDiabetes Mellitus +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A